Aug 25 (Reuters) - CTI Biopharma Corp CTIC.O :
* CTI BIOPHARMA AND DRI HEALTHCARE TRUST ANNOUNCE UP TO $135
MILLION DEBT AND ROYALTY TRANSACTION
* DRI HEALTHCARE TRUST - TRANSACTION TO FUND LAUNCH,
COMMERCIALIZATION OF PACRITINIB IN U.S. IN 2021 PENDING FDA
APPROVAL, AND FUTURE COMMERCIALIZATION
* DRI HEALTHCARE TRUST - TO PROVIDE $50 MILLION CREDIT
FACILITY AT
CLOSING, WILL ALSO PROVIDE CTI WITH $60 MILLION ON RECEIVING
ACCELERATED APPROVAL OF PACTRITINIB
Source text for Eikon: ID:nPn4mHmmsa
Further company coverage: CTIC.O
((Reuters.Briefs@thomsonreuters.com;))